Axsome Therapeutics, Inc. (AXSM)
NASDAQ: AXSM · Real-Time Price · USD
90.73
+0.99 (1.10%)
At close: Dec 20, 2024, 4:00 PM
91.00
+0.27 (0.30%)
After-hours: Dec 20, 2024, 4:52 PM EST
Axsome Therapeutics Market Cap
Axsome Therapeutics has a market cap or net worth of $4.40 billion as of December 20, 2024. Its market cap has increased by 32.31% in one year.
Market Cap
4.40B
Enterprise Value
4.26B
1-Year Change
32.31%
Ranking
Category
Stock Price
$90.73
Market Cap Chart
Since November 19, 2015, Axsome Therapeutics's market cap has increased from $154.90M to $4.40B, an increase of 2,738.60%. That is a compound annual growth rate of 44.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 4.40B | 16.75% |
| Dec 29, 2023 | 3.77B | 12.44% |
| Dec 30, 2022 | 3.35B | 135.22% |
| Dec 31, 2021 | 1.42B | -53.19% |
| Dec 31, 2020 | 3.04B | -14.70% |
| Dec 31, 2019 | 3.57B | 4,141.14% |
| Dec 31, 2018 | 84.10M | -36.58% |
| Dec 29, 2017 | 132.60M | 2.55% |
| Dec 30, 2016 | 129.30M | -21.30% |
| Dec 31, 2015 | 164.30M | 6.07% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alkermes | 4.81B |
| Krystal Biotech | 4.74B |
| Viking Therapeutics | 4.71B |
| TG Therapeutics | 4.62B |
| Integer Holdings | 4.48B |
| PROCEPT BioRobotics | 4.39B |
| Scholar Rock Holding | 4.19B |
| Apellis Pharmaceuticals | 4.13B |